Robert Rosenson, MD Email Robert Rosenson
-
- Position
- PROFESSOR | Medicine, Cardiology
-
- Specialties
- Cardiology
- Cardiovascular Disease
-
- Language
- English
-
- Hospital Affiliation
- The Mount Sinai Hospital
-
- Phone
- The Lauder Family Cardiovascular Ambulatory Center 212-427-1540 212-427-1540
Book an Appointment - Robert Rosenson, MD
Robert S. Rosenson, MD
FACC, FACP, FAHA, FNLA, FACCP (inactive)
Robert S. Rosenson, MD, is Professor of Medicine at the Icahn School of Medicine at Mount where he serves as Director of Cardiometabolic Disorders. He is a Fellow of the American Heart Association Council on Epidemiology and Prevention, Fellow of the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology, Fellow of the National Lipid Association and a past Fellow of the American College of Chest Physicians (inactive). He has been the recipient of a number of awards and honors, including the Ground-Breaking Doctors Award from Chicago magazine. Dr. Rosenson is Co-Editor-In-Chief, Cardiovascular Drugs and Therapy, effective February 1, 2016 and has been elected to the European Academy of Sciences.
Dr. Rosenson earned his medical degree from Tulane University in New Orleans, Louisiana where he conducted research on prostaglandin metabolism in coronary arteries. This work was recognized when he was awarded the Querens-Rives-Shore Award for best thesis in Cardiology. He then served his residency in medicine at Brigham and Women’s Hospital in Boston, Massachusetts. He later completed a fellowship in cardiovascular medicine at the University of Chicago that was followed by an additional year of training as a Research Associate in lipoprotein metabolism.
Dr. Rosenson is a Diplomate of the American Board of Internal Medicine, with a subspecialty in cardiovascular disease, the National Board of Medical Examiners, and National Lipid Association. He currently serves on a number of committees for professional societies. He has served on nine committees for the American College of Cardiology, and he served as a member of the Expert Document Committee for the American College of Cardiology and ACCF Representative to the ADA Aspirin Therapy in Diabetes Position Statement. He has been extensively involved with the National Lipid Association where he serves a National Board Member and Northeast Lipid Association Board Member. Dr. Rosenson served as Co-Chair for the task force on HDL biology, and he is the current Chair of the Statin Safety Expert Muscle Document Committee. Dr. Rosenson led three international working groups on HDL that resulted in seminal articles on HDL nomenclature, HDL and macrophage cholesterol, and HDL functionality.
Dr. Rosenson has been involved in numerous grant-supported research investigations studying the effects of lipid-lowering therapy, hypoglycemic therapy, and antihypertensive agents in inflammation, thrombogenesis, and rheology. His laboratory was the first to demonstrate that statins reduce pro-inflammatory cytokine production. He has continued this work through mechanistic studies on inflammatory markers with studies on fenofibrate. Most recently, he has conducted research with selective inhibitors of inflammatory pathways such as lipoprotein-associated phospholipase A2, and secretory phospholipase A2. He has made important contributions concerning the prognostic significance of lipoprotein subclasses in coronary atherosclerosis, cardiovascular events and prediction of type 2 diabetes. He has served as Principal Investigator on a number of NIH-funded research studies, pharmaceutical-sponsored drug trials, and multicenter studies. He served as Global Principal Investigator of the PLASMA I, PLASMA II and FRANCIS trials. He has authored 230 peer-review journal articles, and nearly 600 book chapters, abstracts, and electronic publications for Up To Date Medicine.
Certifications
Cardiovascular Disease
American Board of Internal Medicine
Clinical Focus
- Acute Coronary Syndrome
- Cardiovascular Disease
- Diabetes
- General Cardiology
- Heart Attack/Acute Coronary Syndrome
- Heart Disease
- Homocystinuria
- Hyperlipidemia/High Cholesterol
- Metabolic Syndrome
- Stroke
- Type 2 Diabetes
Education
MD, Tulane University
Residency, Internal Medicine
Brigham and Women's Hospital, Harvard Medical School
Fellowship, Cardiovascular Disease
University of Chicago Hospitals
Language
English
Download the CV
Simon Dack Award for Outstanding Scholarship
American College of Cardiology
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Rosenson during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- 89 Bio
- Amgen Inc.
- CVS Caremark
- Cleveland Clinic Clinical Research Coordinating Cener
- Corvidia
- Novartis
- The Medicines Company
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- MediMergent LLC
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Amgen Inc.
- Kowa Pharmaceuticals America, Inc.
- Regeneron Pharmaceuticals
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Cleveland Clinic Clinical Research Coordinating Cener
- UpToDate Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.